{'fraction_non_alphanumeric': 0.0532724505327245, 'fraction_numerical': 0.0654490106544901, 'mean_word_length': 4.6239316239316235, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Safety of Colonic Stenting in Malignant Obstruction: A Meta‐Analysis: 1159

statistically signifi cant decrease in stool frequency (OR 0.07; 95% CI: 0.03-0.16, p<0.01). Budesonide also induced statistically signifi cant improvement in histological score in 45 of 62 patients as compared to 12 of 59 patients in control group (OR 0.06; 95% CI: 0.02-0.18, p<0.01). No signifi cant heterogeneity was present for all the major outcomes. Funnel plot revealed no publication bias. Conclusion: Budesonide is eff ective in inducing clinical and histological response in microscopic colitis. Treatment at 9 mg PO daily for 6-8 weeks can provide a favorable response.